FLEX PHARMA INC Chart calendar Flex Pharma Inc
39b213f0fcbd03520.8CPkndEtsW_dKm1sEYsJJM-wDfKBOMPDggP7ZOEE9jI.nELV--gYiCmrbxozUPteaprSWIDQC6CUw3uQJ5FoplDJRcnbgUzDAeVgNA~360b752b1ba328a08f98b7ca82f6b50e
Upcoming events on Flex Pharma Inc
Past events on Flex Pharma Inc
| 2024-03-22 04:05 pm | Q4 2023 Earnings Release |
| 2023-08-10 04:05 pm | Q2 2023 Earnings Release |
| 2023-07-11 | Tumor Models Conference |
| 2023-06-14 11:00 am | Annual General Meeting |
| 2023-06-07 | European Hematology Association Hybrid Congress |
| 2023-06-04 | BIO International Convention |
| 2023-05-11 08:00 am | Q1 2023 Earnings Release |
| 2023-04-19 09:00 am | American Association for Cancer Research Meeting - Abstract No 6253 |
| 2023-04-16 01:30 pm | American Association for Cancer Research Meeting - Abstract No 524 |
| 2023-04-05 11:00 am | Diamond Equity Research Research Emerging Growth Invitational Conference |
| 2023-03-27 08:30 am | Q4 2022 Earnings Release |
| 2023-01-25 | Molecular Glue Drug Development Summit |
| 2022-12-14 11:00 am | Business Update Call |
| 2022-12-12 | American Society of Hematology Meeting - Abstract No 170138 |
| 2022-12-12 | American Society of Hematology Meeting - Abstract No 167495 |
| 2022-11-10 08:30 am | Q3 2022 Earnings Release |
| 2022-10-26 05:30 pm | Targeted Protein Degradation Summit |
| 2022-10-05 | American Association of Cancer Research Special Conference |
| 2022-09-29 10:30 am | Ladenburg Thalmann Healthcare Conference |
| 2022-08-08 11:00 am | Interim 2022 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 3,47 3,32 4.37% | 5,23 5,25 -0.25% | 1,84 3,14 -41.3% | 0,00 0,00 - | 0,00 | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 0,00 - | -7,79 -8,04 3.11% | 0,00 0,00 - | 0,00 0,00 - | 0,00 | -22,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -12,8 -13,0 1.78% | 0,00 0,00 - | 0,00 | 0,00 |
|
Net income Million USD | Released Forecast Spread | 0,00 0,00 - | -7,35 -7,59 3.17% | -12,8 -13,0 1.78% | -31,6 -22,3 -41.82% | -12,5 | -21,9 |
|
EPS USD | Released Forecast Spread | 0,00 0,00 - | -12,5 -13,8 9.09% | -7,75 -7,50 -3.33% | 0,00 -0,85 - | -3,84 | -26,8 |
| Announcement Date | 23/03/20 | 18/03/21 | 10/03/22 | 27/03/23 | 22/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,33 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -4,14 -3,55 -16.92% | -5,42 -5,97 9.25% | -3,97 -4,71 15.72% | -2,53 -4,02 37% | |||||||||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -4,10 -3,71 -10.62% | -5,34 | |||||||||||
|
Net income Million USD | Released Forecast Spread | -4,10 -3,68 -11.63% | -6,11 -4,32 -41.35% | -4,72 -4,52 -4.5% | -14,4 -4,94 -191.87% | -6,37 -5,79 -10.01% | -5,34 -5,95 10.21% | -3,88 -4,69 17.26% | -2,44 -3,97 38.46% | |||||
|
EPS USD | Released Forecast Spread | -2,25 -2,00 -12.5% | -3,25 -2,25 -44.44% | -2,25 -2,50 10% | -6,41 -2,25 -184.89% | -2,75 -2,24 -22.77% | -2,23 -2,43 8.04% | -1,43 -1,30 -10.28% | -0,65 -1,34 51.31% | -6,70 | -6,70 | -6,70 | -6,71 | -5,85 |
| Announcement Date | 10/03/22 | 12/05/22 | 05/08/22 | 10/11/22 | 27/03/23 | 11/05/23 | 10/08/23 | 09/11/23 | - | - | - | - | - |
More events
